In April, the American Society of Clinical Oncology (ASCO) released a policy statement recommending how to fix the 340B Drug Pricing Program.
[ Read More ]
We use cookies to ensure that we give you the best experience on our website. By continuing to browse the site, you are agreeing to this use and our Privacy Policy.
Subscribe